Abstract | PURPOSE: METHODS: The study was designed as a prospective, single center, randomised, placebo controlled, double-blinded trial. Eighty-eight consecutive patients with non-infective, non- contact lens related traumatic or foreign body removal related corneal abrasions were recruited to this study. They were randomised into two groups. Both groups were given a single instillation of Gutt. cyclopentolate 0.5% followed by chloramphenicol eye ointment four times a day until the following day. In addition, the treatment group received topical Ketorolac trometamol 0.5% ophthalmic solution while the control group received placebo Liquifilm tears. Patients were assessed at presentation and about twenty-four hours later for subjective symptoms, abrasion size and any associated complications. RESULTS: There was no statistical difference in the two groups at base line and twenty-four hour follow-up when assessed for five subjective symptoms of pain, photophobia, grittiness, watering and blurring of vision. However, those receiving topical ketorolac required significantly less additional oral analgesics (p=0.001). There was no difference in the rate of healing. CONCLUSION:
|
Authors | R Goyal, J Shankar, D L Fone, D S Hughes |
Journal | Acta ophthalmologica Scandinavica
(Acta Ophthalmol Scand)
Vol. 79
Issue 2
Pg. 177-9
(Apr 2001)
ISSN: 1395-3907 [Print] Denmark |
PMID | 11284758
(Publication Type: Clinical Trial, Evaluation Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Ketorolac Tromethamine
|
Topics |
- Administration, Topical
- Adult
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Cornea
(drug effects)
- Corneal Injuries
- Double-Blind Method
- Drug Evaluation
- Eye Foreign Bodies
(complications)
- Eye Injuries
(drug therapy, etiology)
- Female
- Humans
- Ketorolac Tromethamine
(therapeutic use)
- Male
- Prospective Studies
- Treatment Outcome
- Wound Healing
(drug effects)
|